Teleconsultation in Ambulatory Care in France
TELET
Observational Study of the Use of the Service Giving Access to Teleconsultation in France by Telemedicine Companies
1 other identifier
observational
84,000
1 country
1
Brief Summary
Teleconsultation is a telemedicine medical act carried out remotely via information and communication technologies. This medical procedure has been legal in France since 2010 and reimbursed by the National Health Insurance under certain conditions since 2018. In 2020, following the COVID-19 epidemic, the lockdowns and the extension of the scope of financial coverage, 17 million teleconsultations have been reimbursed. To date, few scientific studies have been published in France to precisely describe the use of the service giving access to outpatient teleconsultation, in particular since the major increase in activity linked to the COVID-19 epidemic. The objective is to describe the use of the service giving access to outpatient teleconsultation carried out in France by teleconsultation companies and compare the use of the teleconsultation service according to the medical density of the territory.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 21, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 21, 2022
CompletedFirst Submitted
Initial submission to the registry
March 25, 2022
CompletedFirst Posted
Study publicly available on registry
April 5, 2022
CompletedApril 5, 2022
April 1, 2022
2 months
March 25, 2022
April 4, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Rate of patients without a treating doctor
Through the study completion at the time of the teleconsultation, average 1 day
Eligibility Criteria
Patients registered with a teleconsultation company member of the LET participating to the study with at least one teleconsultation during the study period.
You may qualify if:
- Patient who used the teleconsultation access service with one of the telemedicine companies member of the LET participating in the study
- Patient residing in France according to the written information (address and or postal code) given at registration to the telemedicine company
- Teleconsultation service used between August 1, 2021 and November 30, 2021
- Teleconsultation service used in the context of outpatient care (hospitals excluded)
- Teleconsultation service used for a teleconsultation with a doctor registered with the Medical Doctors Council in France
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Les Entreprises de Télémédecine
Paris, France
Related Publications (1)
Ohannessian R, Yaghobian S, Simon R, Poinsot-Chaize G, Hiridjee S, Gleize JC, Pierme JP, Amar N, Merlaud C, Maudoux C, Zerah B, Lescure F, Salomon J. Evaluating the Impact of Teleconsultations on Access to Ambulatory Primary Care in Medically Underserved Areas: A National Observational Cross-Sectional Multicenter Study. Telemed J E Health. 2024 Feb;30(2):570-578. doi: 10.1089/tmj.2023.0274. Epub 2023 Aug 29.
PMID: 37643308DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Julie Salomon, MD
Qare
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 25, 2022
First Posted
April 5, 2022
Study Start
February 1, 2022
Primary Completion
March 21, 2022
Study Completion
March 21, 2022
Last Updated
April 5, 2022
Record last verified: 2022-04
Data Sharing
- IPD Sharing
- Will not share